分子ヒトパピローマウイルス(HPV)診断機器の世界市場動向・分析2018-2025

QYResearchが発行した調査報告書(QYR8D06772)
◆英語タイトル:Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D06772
◆発行会社(リサーチ会社):QYResearch
◆発行日:2018年12月6日(※2024年版があります。お問い合わせください。)
◆ページ数:129
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥828,800見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD11,200 ⇒換算¥1,657,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、分子ヒトパピローマウイルス(HPV)診断機器の世界市場について調査・分析し、種類別には、サービス、アッセイキット、システムに、用途別には、病院、クリニックに区分してまとめました。調査対象企業は、F. Hoffmann-La Roche Ltd.、Agilent Technologies, Inc.、Becton, Dickinson and Company、Qiagen N.V.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Hologic Inc.、Cepheid Inc.、Seegene Inc.、Takara Bio Inc.、DaAn Gene Co., Ltd. of Sun Yat-Sen University、Promega Corporation、Greiner Bio-One International GmbH (Greiner Holding AG)、Enzo Biochem Inc.、Norgen Biotek Corp.、DiagCor Bioscience Inc Ltd、Hybribio Limited、Zytovision GmbH、Arbor Vita Corporation、Medical & Biological Laboratories Co., Ltd、Fujirebio Diagnostics, Inc.等です。

・レポートの概要
・グローバル成長トレンド
・分子ヒトパピローマウイルス(HPV)診断機器の世界市場規模
・分子ヒトパピローマウイルス(HPV)診断機器の地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別分子ヒトパピローマウイルス(HPV)診断機器の価格動向
・分子ヒトパピローマウイルス(HPV)診断機器の種類別市場規模(サービス、アッセイキット、システム)
・分子ヒトパピローマウイルス(HPV)診断機器の用途別市場規模(病院、クリニック)
・分子ヒトパピローマウイルス(HPV)診断機器の北米市場(アメリカ、カナダ、メキシコ)
・分子ヒトパピローマウイルス(HPV)診断機器のヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・分子ヒトパピローマウイルス(HPV)診断機器のアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・分子ヒトパピローマウイルス(HPV)診断機器の中南米市場(ブラジル等)
・分子ヒトパピローマウイルス(HPV)診断機器の中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報(F. Hoffmann-La Roche Ltd.、Agilent Technologies, Inc.、Becton, Dickinson and Company、Qiagen N.V.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Hologic Inc.、Cepheid Inc.、Seegene Inc.、Takara Bio Inc.、DaAn Gene Co., Ltd. of Sun Yat-Sen University、Promega Corporation、Greiner Bio-One International GmbH (Greiner Holding AG)、Enzo Biochem Inc.、Norgen Biotek Corp.、DiagCor Bioscience Inc Ltd、Hybribio Limited、Zytovision GmbH、Arbor Vita Corporation、Medical & Biological Laboratories Co., Ltd、Fujirebio Diagnostics, Inc.)
 -企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・分子ヒトパピローマウイルス(HPV)診断機器の市場規模予測
・分子ヒトパピローマウイルス(HPV)診断機器の種類別市場予測2018-2025(サービス、アッセイキット、システム)
・分子ヒトパピローマウイルス(HPV)診断機器の用途別市場予測2018-2025(病院、クリニック)
・分子ヒトパピローマウイルス(HPV)診断機器の北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・分子ヒトパピローマウイルス(HPV)診断機器のヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・分子ヒトパピローマウイルス(HPV)診断機器のアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・分子ヒトパピローマウイルス(HPV)診断機器の中南米市場予測2018-2025(ブラジル等)
・分子ヒトパピローマウイルス(HPV)診断機器の中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論
【レポートの概要】

HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. According to CDC, about 1% of sexually active men in the U.S. have genital warts at any given time. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men. The selective product availability has restricted the growth of the market to a specific gender leading to slow growth over the forecast period.The Molecular Human Papillomavirus (HPV) Diagnostic Equipment market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Molecular Human Papillomavirus (HPV) Diagnostic Equipment.

This study focuses on the production side and consumption side of Molecular Human Papillomavirus (HPV) Diagnostic Equipment, presents the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
In terms of production side, this report researches the Molecular Human Papillomavirus (HPV) Diagnostic Equipment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Molecular Human Papillomavirus (HPV) Diagnostic Equipment by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
F. Hoffmann-La Roche Ltd.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene Co., Ltd. of Sun Yat-Sen University
Promega Corporation
Greiner Bio-One International GmbH (Greiner Holding AG)
Enzo Biochem Inc.
Norgen Biotek Corp.
DiagCor Bioscience Inc Ltd
Hybribio Limited
Zytovision GmbH
Arbor Vita Corporation
Medical & Biological Laboratories Co., Ltd
Fujirebio Diagnostics, Inc.

Market Segment by Product Type
Services
Assay kits
System

Market Segment by Application
Hosptial
Clinic

Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa

The study objectives are:
To analyze and research the global Molecular Human Papillomavirus (HPV) Diagnostic Equipment status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Molecular Human Papillomavirus (HPV) Diagnostic Equipment manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Molecular Human Papillomavirus (HPV) Diagnostic Equipment are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size Growth Rate by Type
1.3.2 Services
1.3.3 Assay kits
1.3.4 System
1.4 Market Segment by Application
1.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share by Application (2018-2025)
1.4.2 Hosptial
1.4.3 Clinic
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value 2013-2025
2.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production 2013-2025
2.1.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity 2013-2025
2.1.4 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2018-2025
2.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Size CAGR of Key Regions
2.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity by Manufacturers
3.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue by Manufacturers (2013-2018)
3.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market Concentration Ratio (CR5 and HHI)
3.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Price by Manufacturers
3.4 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Molecular Human Papillomavirus (HPV) Diagnostic Equipment Market
3.6 Key Manufacturers Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Services Production and Production Value (2013-2018)
4.1.2 Assay kits Production and Production Value (2013-2018)
4.1.3 System Production and Production Value (2013-2018)
4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Market Share by Type
4.3 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Market Share by Type
4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application

6 Production by Regions
6.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production (History Data) by Regions 2013-2018
6.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2013-2018
6.3.2 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.3.3 Key Players in United States
6.3.4 United States Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.4 Europe
6.4.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2013-2018
6.4.2 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.4.3 Key Players in Europe
6.4.4 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.5 China
6.5.3 Key Players in China
6.5.2 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.5.3 Key Players in China
6.5.4 China Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.6 Japan
6.6.1 Japan Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Growth Rate 2013-2018
6.6.2 Japan Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Growth Rate 2013-2018
6.6.3 Key Players in Japan
6.6.4 Japan Molecular Human Papillomavirus (HPV) Diagnostic Equipment Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia

7 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Regions
7.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.2.2 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.2.3 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.3.2 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.3.3 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.4.2 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.4.3 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.4.4 China
7.4.5 Japan
7.4.6 Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.5.2 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application
7.5.3 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Type
7.6.2 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption by Application

8 Company Profiles
8.1 F. Hoffmann-La Roche Ltd.
8.1.1 F. Hoffmann-La Roche Ltd. Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.1.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.1.5 F. Hoffmann-La Roche Ltd. Recent Development
8.2 Agilent Technologies, Inc.
8.2.1 Agilent Technologies, Inc. Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.2.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.2.5 Agilent Technologies, Inc. Recent Development
8.3 Becton, Dickinson and Company
8.3.1 Becton, Dickinson and Company Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.3.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.3.5 Becton, Dickinson and Company Recent Development
8.4 Qiagen N.V.
8.4.1 Qiagen N.V. Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.4.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.4.5 Qiagen N.V. Recent Development
8.5 Thermo Fisher Scientific Inc.
8.5.1 Thermo Fisher Scientific Inc. Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.5.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.5.5 Thermo Fisher Scientific Inc. Recent Development
8.6 Abbott Laboratories
8.6.1 Abbott Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.6.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.6.5 Abbott Laboratories Recent Development
8.7 Hologic Inc.
8.7.1 Hologic Inc. Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.7.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.7.5 Hologic Inc. Recent Development
8.8 Cepheid Inc.
8.8.1 Cepheid Inc. Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.8.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.8.5 Cepheid Inc. Recent Development
8.9 Seegene Inc.
8.9.1 Seegene Inc. Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.9.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.9.5 Seegene Inc. Recent Development
8.10 Takara Bio Inc.
8.10.1 Takara Bio Inc. Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Molecular Human Papillomavirus (HPV) Diagnostic Equipment
8.10.4 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Product Introduction
8.10.5 Takara Bio Inc. Recent Development
8.11 DaAn Gene Co., Ltd. of Sun Yat-Sen University
8.12 Promega Corporation
8.13 Greiner Bio-One International GmbH (Greiner Holding AG)
8.14 Enzo Biochem Inc.
8.15 Norgen Biotek Corp.
8.16 DiagCor Bioscience Inc Ltd
8.17 Hybribio Limited
8.18 Zytovision GmbH
8.19 Arbor Vita Corporation
8.20 Medical & Biological Laboratories Co., Ltd
8.21 Fujirebio Diagnostics, Inc.

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Capacity, Production Forecast 2018-2025
9.1.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast 2018-2025
9.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production and Production Value Forecast by Regions
9.2.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast by Regions
9.2.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Forecast by Regions
9.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Forecast by Type
9.4.2 Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Country 2018-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Molecular Human Papillomavirus (HPV) Diagnostic Equipment Consumption Forecast by Countries 2018-2025
10.7.2 Middle East and Africa
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Sales Channels
11.2.2 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Distributors
11.3 Molecular Human Papillomavirus (HPV) Diagnostic Equipment Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

...

【掲載企業】

F. Hoffmann-La Roche Ltd.、Agilent Technologies, Inc.、Becton, Dickinson and Company、Qiagen N.V.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Hologic Inc.、Cepheid Inc.、Seegene Inc.、Takara Bio Inc.、DaAn Gene Co., Ltd. of Sun Yat-Sen University、Promega Corporation、Greiner Bio-One International GmbH (Greiner Holding AG)、Enzo Biochem Inc.、Norgen Biotek Corp.、DiagCor Bioscience Inc Ltd、Hybribio Limited、Zytovision GmbH、Arbor Vita Corporation、Medical & Biological Laboratories Co., Ltd、Fujirebio Diagnostics, Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 分子ヒトパピローマウイルス(HPV)診断機器の世界市場動向・分析2018-2025(Global Molecular Human Papillomavirus (HPV) Diagnostic Equipment Industry Research Report, Growth Trends and Competitive Analysis 2018-2025)]についてメールでお問い合わせはこちらでお願いします。